“ABLE is a forum for entrepreneurs to network and learn from biotech industry leaders,” Subramani Ramachandrappa (Subbu)

2016-09-13 07:34:34

Mr Subramani Ramachandrappa (Subbu) is the treasurer of Association of Biotechnology-Led Enterprises (ABLE), handling the critical task of keeping the organization’s finances in fine fettle. He is also the Founder and CEO of Richcore Lifesciences, a Privae Equity funded company focused on developing innovative enzyme solutions for Clean-tech and Bio-pharma applications. He is an Engineer and MBA

Read more

CDSCO extends BA/BE studies’ validity of approval to 3 years

2016-09-12 10:22:51

To alleviate the problems of the industry, CDSCO has announced that it will extend the validity period of approvals granted to facilities conducting BA/BE studies to three years.    By Team ABLECurrently approval of the Bioavailability/Bioequivalence study center along with Bioanalytical laboratory to conduct Bioavailability/ Bioequivalence studies is given by CDSCO after inspection

Read more

Swagene launches new series for genetic diagnostics under the brand Swaviva

2016-09-12 10:20:41

Chennai-based molecular diagnostic startup Swagene has launched consumer genetics services tagged with a brand name called Swaviva. The Swaviva diagnostics  target sports, hair fall, diabetes and obesity.By Team ABLESwagene, which commenced its R&D operations in 2014, has announced the launch of lifestyle genetics under a new brand name , Swaviva. “A lot of people have worries and

Read more

Kintetsu World Express opens pharma warehouse in Hyderabad airport

2016-09-12 07:39:54

The Indian subsidiary of Kintetsu World Express (KWE), KWE India has opened the country’s first Good Distribution Process (GDP) warehouse at the Hyderabad airport cargo satellite building. This facility will exclusively handle pharmaceutical logistics. KWE India Managing Director Mineo Suzuki inaugurated the facility. KWE says that the company has become the first to set up a unique and one of t

Read more

Takeda initiates global phase 3 clinical trial of Dengue Vaccine

2016-09-12 07:37:59

The study will evaluate vaccine protection against all four strains of dengue virus, regardless of previous exposureTakeda Pharmaceutical Company Limited has announced that it has vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study (TIDES), a phase 3 double-blind, randomized and placebo-controlled trial of its live-attenuated tetravalent dengue vaccine candid

Read more

Global coalition CEPI formed to tackle infectious diseases

2016-09-08 13:55:05

India’s vaccine industry and government are preparing to play a key role in the newly formed global coalition, CEPI (Coalition for Epidemic Preparedness Innovation), to be chaired  in the interim by DBT secretary, Dr K VijayRaghavan.By Team ABLEThe decision to play an active role and offering India’s immense expertise in vaccine production and other capabilities in this new coalition, CEP

Read more

Nagaland to host India Diabetes Study

2016-09-08 09:11:11

ICMR in collaboration with Madras Diabetes Research Foundation will initiate the India Diabetes Study in Nagaland through the Department of Health and Family Welfare.By Team ABLEThe Indian Council of Medical Research (ICMR) in collaboration with Madras Diabetes Research Foundation, Chennai has been carrying out a nation-wide study called “India Diabetes Study” and has also decided to cover the

Read more

Syngene establishes dedicated R&D center for Amgen

2016-09-08 09:06:52

Syngene International has established an integrated, multi-disciplinary drug discovery and development center for Amgen Inc.By Team ABLEBengaluru-located R&D focused contract research organization Syngene International has announced the establishment of an integrated, multi-disciplinary drug discovery and development center for globally acclaimed Amgen Inc. This center, named Syngene Amgen Res

Read more

JIPMER’s biotech department to collaborate for translational research

2016-09-08 09:04:48

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in Puduchery will sign a memorandum of understanding with the Translational Health Science and Technology Institute (THSTI) of HaryanaBy Team ABLEPuducherry-located premier medical institution, the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), will sign a memorandum of understanding with th

Read more

DST commits Rs 500 crore for meeting PM’s Vision on Startup India

2016-09-08 08:54:45

In order to realize the Prime Minister’s ambitious initiative on “Startup India”, DST aims to bring both speed and scale to transform the Startup Ecosystem in the country and has committed Rs 500 crore to implement these new programs in next few years.By Team ABLEThe Union Minister for Science & Technology and Earth Sciences, Dr Harsh Vardhan, announced Rs 500 crore support to startups t

Read more